n-methylaspartate has been researched along with CJD (Creutzfeldt-Jakob Disease) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertani, I; Chiesa, R; Foray, C; Iori, V; Mantovani, S; Maroso, M; Tonini, R; Trusel, M; Vezzani, A | 1 |
1 other study(ies) available for n-methylaspartate and CJD (Creutzfeldt-Jakob Disease)
Article | Year |
---|---|
Inhibition of IL-1β Signaling Normalizes NMDA-Dependent Neurotransmission and Reduces Seizure Susceptibility in a Mouse Model of Creutzfeldt-Jakob Disease.
Topics: Animals; Creutzfeldt-Jakob Syndrome; Disease Models, Animal; Disease Susceptibility; Female; Hippocampus; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; N-Methylaspartate; Neuronal Plasticity; Random Allocation; Receptors, N-Methyl-D-Aspartate; Seizures; Signal Transduction; Synaptic Transmission | 2017 |